18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies

Brandon A Howard; Terence Z Wong

doi:10.1016/j.rcl.2021.06.001

18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies

Radiol Clin North Am. 2021 Sep;59(5):737-753. doi: 10.1016/j.rcl.2021.06.001.

Authors

Brandon A Howard¹, Terence Z Wong²

Affiliations

¹ Division of Nuclear Medicine and Radiotheranostics, Department of Radiology, Duke University Medical Center, DUMC Box 3949, 2301 Erwin Road, Durham, NC 27710, USA. Electronic address: brandon.howard@duke.edu.
² Division of Nuclear Medicine and Radiotheranostics, Department of Radiology, Duke University Medical Center, DUMC Box 3949, 2301 Erwin Road, Durham, NC 27710, USA.

PMID: 34392916
DOI: 10.1016/j.rcl.2021.06.001

Abstract

Gastrointestinal malignancies encompass a variety of primary tumor sites, each with different staging criteria and treatment approaches. In this review we discuss technical aspects of 18F-FDG-PET/CT scanning to optimize information from both the PET and computed tomography components. Specific applications for 18F-FDG-PET/CT are summarized for initial staging and follow-up of the major disease sites, including esophagus, stomach, hepatobiliary system, pancreas, colon, rectum, and anus.

Keywords: Anus; Cancer; Colon; Esophagus; Hepatobiliary; Pancreas; Rectum; Stomach.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18
Gastrointestinal Neoplasms / diagnostic imaging*
Gastrointestinal Neoplasms / pathology*
Humans
Neoplasm Staging
Positron Emission Tomography Computed Tomography / trends*
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18